CASI Pharmaceuticals
CASI
CASI
31 hedge funds and large institutions have $2.59M invested in CASI Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$45K | |
| 2 | +$21K | |
| 3 | +$18K | |
| 4 |
Renaissance Technologies
New York
|
+$6.92K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.61K |
Top Sellers
| 1 | -$43.6K | |
| 2 | -$6.08K | |
| 3 | -$1.97K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$984 |